BJL
CRL icon

Brighton Jones LLC’s Charles River Laboratories CRL Stock Holding History

Brighton Jones LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+935
New +$167K ﹤0.01% 1228
2021
Q3 		– Sell
-775
Closed -$287K – 491
2021
Q2 		$287K Buy
+775
New +$259K 0.01% 357

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Brighton Jones LLC's CRL Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Charles River Laboratories (CRL) in Q2 2026: 935 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in CRL as recently as Q2 2021.

Brighton Jones LLC first reported a position in CRL in Q2 2021 and has held it in 2 quarters since. The position peaked at $287K in Q2 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Brighton Jones LLC held 935 shares of Charles River Laboratories worth $212K as of Q2 2026.
  • Charles River Laboratories was a new Brighton Jones LLC position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1228 holding.
  • Brighton Jones LLC first reported a position in Charles River Laboratories in Q2 2021 and has held it in 2 quarters since.
  • Brighton Jones LLC's Charles River Laboratories position peaked at $287K in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.